DCF — BAYSTATE NOBLE HOSPITAL
Enterprise Value: $-177.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-177.8M
Enterprise Value
$-54.9M
PV of Cash Flows
$-122.8M
PV of Terminal Value
$-197.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $72.5M | $-11.8M | -16.0% | $-14.9M | $-13.5M |
| Year 2 | $74.6M | $-11.4M | -15.0% | $-14.6M | $-12.0M |
| Year 3 | $76.9M | $-11.0M | -14.0% | $-14.2M | $-10.7M |
| Year 4 | $79.2M | $-10.9M | -14.0% | $-14.3M | $-9.7M |
| Year 5 | $81.6M | $-11.0M | -14.0% | $-14.5M | $-9.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-177.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$70.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16765513131368412
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5